caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1114122033

Sara Axelrod-MalagoldM.D., M.P.H.

Allergy/ ImmunologyEast Brunswick, NJI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
520
Unique beneficiaries
—
Total services
8,762
Distinct HCPCS
11
Medicare payment
$78K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 132 Allergy/ Immunology providers in NJ — top quintile (cohort median 3,350).
REFERRAL NETWORK

Where Sara Axelrod-Malagold's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 8 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Laboratory Corporation Of America Holdings
Clinical Laboratory · Raritan, NJ
44150
MERIDIAN HOSPITALS CORPORATION1834
Mary Georgy
Allergy/ Immunology · Brick, NJ
1670
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
Bruce Decotiis
Allergy/ Immunology · Brick, NJ
45130
Laboratory Corporation Of America Holdings
Clinical Laboratory · Raritan, NJ
36108
MERIDIAN HOSPITALS CORPORATION2791
Quest Diagnostics Incorporated
Clinical Laboratory · Clifton, NJ
2297
Mary Georgy
Allergy/ Immunology · Brick, NJ
2178
Laboratory Corporation Of America Holdings
Clinical Laboratory · Burlington, NC
1425
Stephanie Giles
Nurse Practitioner · Freehold, NJ
1439
MERIDIAN HOSPITALS CORPORATION1228
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
511
Beneficiaries
—
Total drug cost
$500K
Distinct drugs
16
Brand share
38.9%
Top prescribed drugs
Montelukast Sodium116 claims
Dupilumab59 claims
Ipratropium Bromide52 claims
Carbinoxamine Maleate30 claims
Omalizumab29 claims
QUALITY · MIPS · 2024
Final MIPS score
94.5
Quality
89.9
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.82%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$872
Payment records
47
By payment type
Food and Beverage$857
Education$15